Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
260.00    0.00 (0.00%)
Bid:
252.00
Ask:
257.00
Spread: 5.00 (1.984%)
Market Cap: £232.84m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Board changes

15 Apr 2026 15:56

RNS Number : 6342A
Wilmington PLC
15 April 2026
 

15 April 2026

 

Wilmington plc

 

Board changes

 

Wilmington plc (LSE: WIL, 'Wilmington', 'the Group'), the GRC RegTech services group, today announces the appointment of three new non-executive directors who will join the board on April 28th 2026 - Christopher Humphrey joins as Senior Independent Director, Dr. Erika Schraner joins as Chair of the Remuneration Committee and Martin Rowland joins as a non-executive director. Christopher will also join the Remuneration and Audit Committees, Martin will join the Audit Committee.

 

Christopher is currently Senior Independent Director of RM plc and was Non-Executive Chair of Heywood Pension Technologies until 20 February 2026, following its acquisition by BlackRock and, until recently (20 January 2025), Chair of AIM-listed Eckoh plc, a position he held since 2017. He also served as Senior Independent Director and Audit Committee Chair at AVEVA Group plc from 2016 to 2023, Senior Independent Director and Audit Committee Chair at Videndum plc from 2013 to 2022, and non-executive director at SDL plc from 2016 to 2023. Chris has had a number of leadership roles during his career, including the position of Group Chief Executive Officer of Anite plc from 2008 to 2015.

 

Erika is currently Senior Independent Director and Chair of the Remuneration Committee at Bytes Technology Group plc, Senior Independent Director at HgCapital Trust plc and Senior Independent Director, Chair of the Nomination Committee and Chair of the Audit Committee at JTC plc. During her executive career, she spent more than 18 years working in Silicon Valley in the technology sector. She held senior professional services roles with Ernst & Young and PricewaterhouseCoopers, and an executive role at with Symantec Corporation, a global cybersecurity company. Earlier in her executive career, she held roles with IBM, REL Consultancy Group and Computer Science Corporation. Through this experience, she developed deep exposure to data and AI-enabled technologies within enterprise software. Erika earned a PhD in management science and engineering at Stanford University. Prior to her current roles, she served as a non-executive director and Chair of the Audit Committee at Videndum plc (2022-2024), non-executive director at Pod Point Group Holdings plc (2021-2025), non-executive director and Chair of the Remuneration Committee at BluJay Solutions Ltd (2021) and non-executive director and Chair of the Audit Committee at Aferian plc (2019-2022).

 

Martin is currently non-executive director and Executive Chair of Centaur Media plc and a non-executive director of Fevera plc. He was previously non-executive director and Chair of Smoove plc (2018-2023) and Chair of Inzpire Group. Prior to this, he held investment roles at LDC, the private equity fund, before moving into an advisory role with businesses.

 

Gordon Hurst, Chair of Wilmington, said

 

"I would like to welcome our three new non-executive directors to the board.  They bring immense experience of the listed company environment with significant experience across international markets, commercial development, M&A and technology."

 

The Group is making this announcement pursuant to UK Listing Rule 6.4.6R with no further disclosures necessary under UK Listing Rule 6.4.8R(1) to (6).

 

For further information, contact:

Wilmington plc

Guy Millward, CFO and Company Secretary

 

Meare Consulting

Adrian Duffield

020 7490 0049

 

 

 

07990 858548

 

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the UK version of Market Abuse Regulation (EU) No. 596/2014, as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement this inside information is now considered to be in the public domain.

 

Notes to Editors

Wilmington plc is an international Governance, Risk and Compliance (GRC) RegTech services group providing a range of regulatory learning & training, regulation intelligence & data capabilities across the HSE (Health, Safety and ESG), legal, data privacy and financial services sectors.

 

The Group has a proprietary RegTech platform with embedded AI, employing the Model Context Protocol (MCP) to interface through an orchestration layer with its many enterprise systems. It has developed its own Autonomous Responsive Intelligence Assistant (ARIA) which enables it to connect or link, manage or automate activities across multiple data repositories, software and different AI models.

 

Wilmington employs over 1,100 people and sells to around 120 countries. Wilmington is listed on the main market of the London Stock Exchange.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAKZGMDDKFGVZM
Date   Source Headline
1st Mar 20171:58 pmRNSVoting Rights and Capital
24th Feb 20172:29 pmRNSDirector/PDMR Shareholding
23rd Feb 20179:36 amRNSInterim Results - Update
23rd Feb 20177:00 amRNSInterim Results
1st Feb 20171:10 pmRNSVoting Rights and Capital
1st Feb 20177:00 amRNSCompletion of Health Service Journal
19th Jan 20177:04 amRNSAcquisition of Health Service Journal
18th Jan 20175:08 pmRNSHolding(s) in Company
17th Jan 20174:43 pmRNSHolding(s) in Company
12th Jan 20179:00 amRNSNotice of Interim Results
3rd Jan 201712:20 pmRNSTotal Voting Rights and Capital
16th Dec 20163:22 pmRNSHolding(s) in Company
1st Dec 20167:00 amRNSVoting Rights and Capital
3rd Nov 20164:03 pmRNSResult of AGM
3rd Nov 20167:00 amRNSAGM and Q1 Trading update
1st Nov 20167:00 amRNSVoting Rights and Capital
17th Oct 201612:53 pmRNSHolding(s) in Company
3rd Oct 201610:05 amRNSVoting Rights and Capital
21st Sep 20162:48 pmRNSDirector/PDMR Shareholdings
20th Sep 201611:54 amRNSShare Awards
16th Sep 20164:31 pmRNSReplacement: Share Awards and Options
16th Sep 20169:10 amRNSShare Awards and Options
14th Sep 20167:00 amRNSFinal Results
2nd Sep 20161:48 pmRNSHolding(s) in Company
1st Sep 20169:39 amRNSVoting Rights and Capital
11th Aug 201610:31 amRNSNotice of Final Results
1st Aug 20169:44 amRNSVoting Rights and Capital
21st Jul 20169:41 amRNSHolding(s) in Company
20th Jul 20167:00 amRNSAcquisition of SWAT
1st Jul 20167:00 amRNSVoting Rights and Capital
10th Jun 20165:04 pmRNSHolding(s) in Company
1st Jun 201611:55 amRNSVoting Rights and Capital
23rd May 201611:57 amRNSHolding(s) in Company
12th May 20167:00 amRNSInterim Management Statement
4th May 20164:05 pmRNSHolding(s) in Company
4th May 20163:54 pmRNSHolding(s) in Company
3rd May 201610:03 amRNSTotal Voting Rights
29th Apr 20169:33 amRNSChange of Company Secretary
1st Apr 20169:33 amRNSTotal Voting Rights
29th Mar 20167:00 amRNSAcquisition
18th Mar 20163:10 pmRNSHolding(s) in Company
11th Mar 20162:03 pmRNSDirector/PDMR Shareholding
1st Mar 20164:37 pmRNSTotal Voting Rights
24th Feb 20167:00 amRNSInterim Results
1st Feb 20169:37 amRNSTotal Voting Rights
19th Jan 20167:00 amRNSAcquisition
15th Jan 20169:52 amRNSHolding(s) in Company
12th Jan 201610:54 amRNSNotification of Interim Results
4th Jan 201611:12 amRNSTotal Voting Rights
17th Dec 20157:00 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.